Skip to main content

Peer Review reports

From: Failure of alemtuzumab therapy in three patients with MOG antibody associated disease

Original Submission
14 Nov 2021 Submitted Original manuscript
15 Dec 2021 Reviewed Reviewer Report
1 Jan 2022 Reviewed Reviewer Report
2 Feb 2022 Author responded Author comments - Sinali O. Seneviratne
Resubmission - Version 2
2 Feb 2022 Submitted Manuscript version 2
4 Feb 2022 Reviewed Reviewer Report
25 Feb 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
2 Mar 2022 Editorially accepted
9 Mar 2022 Article published 10.1186/s12883-022-02612-6

You can find further information about peer review here.

Back to article page